P3 Health Partners raises 2026 adjusted EBITDA guidance range to $90M-$110M as it targets $200M in value creation

• CEO, President & Director Aric Coffman said Q3 “reflect that work with $21 million of adjusted EBITDA, bringing our year-to-date adjusted EBITDA to $101 million,” and added, “we are raising the low end of our full year adjusted

Seeking Alpha's Disclaimer: This article was automatically generated by an AI tool based on content available on the Seeking Alpha website, and has not been curated or reviewed by humans. Due to inherent limitations in using AI-based tools, the accuracy, completeness, or timeliness of such articles cannot be guaranteed. This article is intended for informational purposes only. Seeking Alpha does not take account of your objectives or your financial situation and does not offer any personalized investment advice. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank.